688 results on '"Inoue, Kenichi"'
Search Results
2. Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)
3. Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole
4. Electric-field-assisted fabrication of metal-class thermal-conductive and elastomer-class-flexible composites comprising plasma-surface-modified hexagonal boron nitride and polyrotaxane
5. Impact of distribution of carotid intraplaque neovessels on plaque vulnerability
6. Mechanical properties of composite materials with low-covered polyrotaxane and plasma-surface-modified hexagonal boron nitride
7. Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
8. Thalamocortical control of cell-type specificity drives circuits for processing whisker-related information in mouse barrel cortex
9. Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice
10. Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study
11. Randomised, double-blind, parallel group comparison of Ashitaba ( Angelica Keiskei ) chalcone effects on visceral fat areas and waist circumference of overweight persons
12. Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers
13. 学生が主体的に取り組むブレストアウェアネス
14. Application of Plasma Surface Modification and Slide-ring Polymer Networks for Development of Thermally Conductive Composite Materials
15. 治療抵抗性の潰瘍性大腸炎に上行大動脈内血栓と塞栓性脳梗塞を合併した1例
16. Fabrication of flexible porous slide-ring polymer/carbon nanofiber composite elastomer by simultaneous freeze-casting and cross-linking reaction with dimethyl sulfoxide
17. Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy
18. Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan
19. Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
20. Table tennis for patients with Parkinson’s disease: A single-center, prospective pilot study
21. Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3
22. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
23. Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3–Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3–Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial
24. PS2-4 Phase 1/2 study of HER3-DXd in HER3-expressing metastatic breast cancer: Subgroup analysis by HER2 expression
25. Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole
26. Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting
27. Microendoscopic calcium imaging of the primary visual cortex of behaving macaques
28. Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer
29. A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
30. β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer
31. Neutropenia management with palbociclib in Japanese patients with advanced breast cancer
32. Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial
33. Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients
34. Wear mechanisms of PVD-coated cutting tools during continuous turning of Ti-6Al-4V alloy
35. Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
36. A deep learning-based automated diagnostic system for classifying mammographic lesions
37. Data from MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2−-Advanced Breast Cancer
38. Table S1 from MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2−-Advanced Breast Cancer
39. Pembrolizumab plus chemotherapy in Japanese patients with triple‐negative breast cancer: Results from KEYNOTE‐355
40. Abstract P5-09-01: Neoadjuvant hormonal therapy plus palbociclib versus hormonal therapy plus placebo in women with operable, hormone sensitive and HER2-negative primary breast cancer
41. Abstract PD13-11: PD13-11 Final Overall Survival Analysis of Monarch 2 : A Phase 3 trial of Abemaciclib Plus Fulvestrant in Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
42. Abstract PD7-01: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: A multicenter retrospective study (ROSET-BM study)
43. Thalamocortical control of cell-type specificity drives a circuit for processing whisker-related information in mouse barrel cortex
44. Damage of physical vapor deposition coatings of cutting tools during alloy 718 turning
45. Comparison of TiN-coated tools using CVD and PVD processes during continuous cutting of Ni-based superalloys
46. Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
47. Cross-Linking-Filler Composite Materials of Functionalized Hexagonal Boron Nitride and Polyrotaxane Elastomer
48. Carbon Layer Formation on Hexagonal Boron Nitride by Plasma Processing in Hydroquinone Aqueous Solution
49. Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer
50. Deficiency of CHAMP1, a gene related to intellectual disability, causes impaired neuronal development and a mild behavioural phenotype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.